{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:37:50Z","timestamp":1790800670392,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":660,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jcin.2011.07.016","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T00:58:13Z","timestamp":1321923493000},"page":"1209-1215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents"],"prefix":"10.1016","volume":"4","author":[{"given":"Bimmer E.","family":"Claessen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter C.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Kereiakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Parise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvin","family":"Kedhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Lansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ecaterina","family":"Cristea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnankutty","family":"Sudhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornima","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Simonton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg. W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2011.07.016_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2011.07.016_bib2","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2011.07.016_bib3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2011.07.016_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF03091813","article-title":"Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS?: A meta-analysis of a first-generation vs. a second-generation drug-eluting stent system","volume":"18","author":"Claessen","year":"2010","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jcin.2011.07.016_bib5","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1161\/CIRCULATIONAHA.104.513952","article-title":"Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison","volume":"111","author":"Mauri","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2011.07.016_bib6","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/01.CIR.98.18.1875","article-title":"Vessel size and long-term outcome after coronary stent placement","volume":"98","author":"Elezi","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2011.07.016_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0735-1097(99)00181-3","article-title":"Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization","volume":"34","author":"Schunkert","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2011.07.016_bib8","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jacc.2006.05.068","article-title":"Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents","volume":"48","author":"Elezi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2011.07.016_bib9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/hrt.2007.128595","article-title":"The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis","volume":"94","author":"Habara","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2011.07.016_bib10","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0002-9149(99)00165-4","article-title":"Influence of lesion length on restenosis after coronary stent placement","volume":"83","author":"Kastrati","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2011.07.016_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.CIR.0000153356.72810.97","article-title":"Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents","volume":"111","author":"Mauri","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2011.07.016_bib12","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.299.16.1903","article-title":"Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial","volume":"299","author":"Stone","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2011.07.016_bib13","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2011.07.016_bib14","first-page":"286","article-title":"A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial","volume":"2","author":"Serruys","year":"2006","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2011.07.016_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2011.07.016_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ahj.2009.07.025","article-title":"SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease","volume":"158","author":"Nikolsky","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2011.07.016_bib17","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2011.07.016_bib18","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2011.07.016_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jcin.2009.05.024","article-title":"Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer: the LEADERS trial substudy","volume":"2","author":"Wykrzykowska","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2011.07.016_bib20","first-page":"58","article-title":"A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial","volume":"1","author":"Serruys","year":"2005","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2011.07.016_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.RES.0000233379.92010.fd","article-title":"Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation","volume":"99","author":"St\u00e4hli","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jcin.2011.07.016_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/01.ATV.0000254677.12861.b8","article-title":"Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents","volume":"27","author":"Muldowney","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcin.2011.07.016_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents","volume":"52","author":"Joner","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2011.07.016_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/CIRCINTERVENTIONS.108.831800.108.831800","article-title":"Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial","volume":"2","author":"Claessen","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2011.07.016_bib25","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2007.01.069","article-title":"Polymer-based, paclitaxel-eluting TAXUS Liberte stent in de novo lesions: the pivotal TAXUS ATLAS trial","volume":"49","author":"Turco","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2011.07.016_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jcin.2008.09.007","article-title":"Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberte stent: 1-year results from the TAXUS ATLAS program","volume":"1","author":"Turco","year":"2008","journal-title":"J Am Coll Cardiol Intv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879811006935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879811006935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:57:07Z","timestamp":1761847027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879811006935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1936879811006935"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2011.07.016","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2011.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}